These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28581873)

  • 41. A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
    Bagel J; Zapata J; Nelson E
    J Drugs Dermatol; 2018 Aug; 17(8):845-850. PubMed ID: 30124723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
    Griffiths CE; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Møller A; Paul C
    Eur J Dermatol; 2018 Jun; 28(3):356-363. PubMed ID: 29952297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis.
    Gold LS; Hansen JB; Patel D; Veverka KA; Strober B
    J Am Acad Dermatol; 2020 Jul; 83(1):131-138. PubMed ID: 32430142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs.
    Feldman SR; Levi E; Pathak P; Kakatkar S; Balkrishnan R
    Skinmed; 2016; 14(4):266-272. PubMed ID: 27784515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
    Kim ES; Frampton JE
    Drugs; 2016 Oct; 76(15):1485-1492. PubMed ID: 27663245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
    Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
    J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized Trials.
    Veverka KA; Hansen JB; Yaloumis M; Kircik L; Stein Gold L
    J Drugs Dermatol; 2021 Aug; 20(8):822-828. PubMed ID: 34397196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab.
    Bagel J; Nelson E
    J Drugs Dermatol; 2022 Mar; 21(3):235-240. PubMed ID: 35254755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
    White S; Vender R; Thaçi D; Haverkamp C; Naeyaert JM; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
    Am J Clin Dermatol; 2006; 7(3):177-84. PubMed ID: 16734505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data.
    Megna M; Cinelli E; Camela E; Fabbrocini G
    Expert Rev Clin Immunol; 2020 Jun; 16(6):599-620. PubMed ID: 32476507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV; Kragballe K
    Int J Dermatol; 2006 Aug; 45(8):970-5. PubMed ID: 16911387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).
    Warren RB; Gold M; Gooderham M; Kircik LH; Lacour JP; Laws P; Liljedahl M; Lynde C; Mørch MH; Sondermann W; Thaçi D
    J Drugs Dermatol; 2021 Apr; 20(4):436-441. PubMed ID: 33852252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.
    Del Rosso JQ
    Cutis; 2014 Sep; 94(3):127-34. PubMed ID: 25279474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
    Bagel J; Levi E; Tyring S; Knuckles ML
    J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Back to the future: a new topical approach for mild-to-moderate psoriasis.
    Girolomoni G; Calzavara Pinton P; Cristaudo A; Cicchetti A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):375-382. PubMed ID: 27982547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
    Queille-Roussel C; Rosen M; Clonier F; Nørremark K; Lacour JP
    Clin Drug Investig; 2017 Apr; 37(4):355-361. PubMed ID: 27995521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
    Charakida A; Dadzie O; Teixeira F; Charakida M; Evangelou G; Chu AC
    Expert Opin Pharmacother; 2006 Apr; 7(5):597-606. PubMed ID: 16553575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.
    Paul C; Stein Gold L; Cambazard F; Kalb RE; Lowson D; Bang B; Griffiths CE
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):119-126. PubMed ID: 27531752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.